Migraine is a prevalent illness in the US, with 39 million people in the country suffering from it. According to the Migraine Research Foundation, it ranks third among the most common illnesses. In the US alone. At least one of four members of a household suffers from the condition.
The Mayo Clinic defines migraines as a severe form of headaches, whose symptoms include pulsating pain in the temples or on one side of the head. Nausea, as well as light and sound sensitivity, could also occur alongside the pain. Unlike the typical tension headache, migraine lasts longer and can take several hours — even days. It is very disruptive to a person’s day, and migraine sufferers, more often than not, have to take time off work during attacks.
Why Join a Clinical Trial
Migraine medications don’t cure the illness. They just address the symptoms. You might have tried a lot of medicines but haven’t found the right one that works for you. In this case, you may want to consider joining a clinical trial.
There are a lot of organizations that compile a list of trials conducted by various clinical research institutions in the country. There are also independent institutions, such as Jean Brown Research, that sponsor migraine trials for pharmaceutical companies.
The Clinical Trial
A clinical trial involves testing a new medication produced by a pharmaceutical company before they release it to the market. Before people can to participate in the trial, trial companies screen participants based on a set of criteria. It may include age, gender, and medical history. Before signing up, prepare some questions about the specifics of the trial. You should ask about the duration, your indirect costs, and the treatment method involved.
Length of the Study
The study’s duration depends on how many phases the treatment has, as well as the kinds of experiments involved. Some studies take 28 to 36 weeks, while others could take years. Understand that the length of the trial could affect your work and life. As such, see to it that you are thoroughly informed of the consequences of participating in the trial.